Ullman Quoted on FDA Warning Letters

October 23, 2020 | Compliance Investigations & White Collar

Marc Ullman was cited in the NutraIngredients-USA article, “FDA takes aim at claims for infant food allergy prevention.”

Two companies have received warning letters from the FDA for claiming that their products can prevent young children from developing certain food allergies.

Marc states that the companies can petition the FDA for a broadening of the qualified health claim, but they need to be vigilant on claims language.

Click here to read the article.

Share this article:

Related News

Get legal updates and news delivered to your inbox